Mesoblast Ltd（MESO）の財務MESOMesoblast Ltd

Evaluating the bottom line, Mesoblast Limited maintains a gross margin of 85.19%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -60.31%, while the net margin is -78.22%. These profitability ratios, combined with a Return on Equity (ROE) of -18.22%, provide a clear picture of how effectively MESO converts its operational activities into shareholder value.

In the context of the broader market, MESO competes directly with industry leaders such as DYN and NRIX. With a market capitalization of $1.86B, it holds a significant position in the sector. When comparing efficiency, MESO's gross margin of 85.19% stands against DYN's N/A and NRIX's 100.00%. Such benchmarking helps identify whether Mesoblast Limited is trading at a premium or discount relative to its financial performance.

Mesoblast reported a revenue of $120.3 million for FY 2026, a 600% increase from $17.2 million in the previous year, with a narrowed net loss of $57.5 million, down 44% from $102.1 million.